Revenue line 1: single-visit pricing

The base revenue line for almost every mobile IV operator. A patient books a single drip session, the operator (or contracted nurse) shows up at their home, hotel, gym, or office, performs the IV insertion, and leaves once the drip is complete (typically 30-60 minutes).

Pricing benchmarks by market tier:

Tier 1 metros: $250 to $600 per visit depending on drip type. Hangover basics $250-350, NAD+ $400-600, custom blends $300-500.

Tier 2 metros: $180 to $450 per visit. Hangover basics $180-280, NAD+ $325-475, custom blends $225-400.

Tier 3 metros: $150 to $350 per visit. Hangover basics $150-225, NAD+ $275-400, custom blends $200-350.

Margin profile on single visits: typically 35 to 55 percent gross margin after IV bag cost ($25-50), additive cost ($15-40), nurse cost ($65-120 per visit), and supplies. Net after fixed costs (vehicle, insurance, scheduling tool) usually lands at 18 to 30 percent.

Revenue line 2: membership and package sales

Most operators add a membership tier in year 2. Pricing structure typically: 4 IVs/month for $X, 8 IVs/month for $Y, 12 IVs/month for $Z. The discount per drip versus single-visit pricing usually lands at 20 to 35 percent.

What this gains the operator:

Predictable recurring revenue (huge for cash flow planning).

Higher lifetime value per patient. A weekly customer at 4x $200 = $800 monthly vs. one-off at $300.

Lower customer acquisition cost amortized over more drips.

Margin profile on memberships: lower per-drip gross margin (typically 22-38 percent), but the volume and predictability more than compensate. Net annual contribution per member often 1.8 to 3x what a recurring single-visit customer produces.

Revenue line 3: B2B partnerships

The high-leverage but slow-to-build channel. Hotels, day spas, gyms, country clubs, sports teams, and corporate wellness programs all see customers who could benefit from on-demand IV therapy.

Three common contract structures:

Referral fee: venue gets a flat $25-50 per referred booking. Simple, easy to scale, lowest commitment for both sides.

White label: operator delivers IV under the venue’s brand. Higher margin to the operator per visit, the venue takes 30-40% of the per-drip revenue.

Retainer + variable: monthly retainer ($500-2,500) for guaranteed response time and dedicated slot windows, plus per-drip fees on top. Common with corporate wellness programs.

Sales cycle for B2B partnerships typically runs 60 to 180 days from first conversation to first booked drip. Worth the wait if you can land 3-5 active partnerships in a metro. The bookings produced are predictable and require zero marketing spend per drip.

Unit economics that actually work

A solo operator with one part-time nurse working a Tier 2 metro can target $25,000 to $45,000 monthly gross revenue at maturity. That breaks down typically as:

Single visits: 50-65% of revenue, $15,000-25,000 monthly.

Membership: 20-35% of revenue, $7,500-12,500 monthly.

B2B partnerships: 10-20% of revenue, $3,000-7,500 monthly.

Total monthly bookings to support this: 80-160 drips per month. Maintenance marketing spend $2,500-5,000 monthly. Operating margin (after all costs including the operator’s own pay) typically 18-25 percent of gross revenue.

Common scaling mistakes

Hiring a second nurse before booking density supports it. If the existing nurse averages 4-6 drips per shift, a second nurse will halve average drips per nurse and crater unit economics. Wait until current nurse hits 8+ drips daily consistently before expanding.

Adding service zones too broadly. Expanding from one metro into three adjacent ones triples marketing complexity, dilutes Map Pack ranking signals, and rarely produces proportional revenue lift in year one. Better: dominate one metro first, then expand.

Underpricing NAD+. Patients who buy NAD+ are willing to pay premium pricing. Operators who price NAD+ at $250 are leaving 40-60% margin on the table.